LONDON -(Dow Jones)- Elan Corporation PLC (ELN.LN), a neuroscience-based biotechnology company, said Friday that the expiration and final results of the tender offer for the 7.75% Senior Fixed Rate Notes due 2011 issued by its wholly-owned subsidiaries, ...
[Morningstar UK - 10/30/2009]